Population modeling of Modified Risk Tobacco Products accounting for smoking reduction and gradual transitions of relative risk

Nicotine and Tobacco Research

Volumn 19, Issue 11, 2017, Pages 1277-1283

  Poland, Bill ^a   Teischinger, Florian ^b  

^a CERTARA   (United States)

^b JT International SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CONVENTIONAL CIGARETTES PER DAY; HEALTH IMPACT ASSESSMENT; HEALTH STATUS; MORTALITY; POPULATION MODEL; POPULATION RISK; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIMULATION; SMOKING; SMOKING CESSATION; TOTAL QUALITY MANAGEMENT; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; FOOD AND DRUG ADMINISTRATION; HARM REDUCTION; HUMAN; PROCEDURES; RISK; STATISTICAL MODEL; TOBACCO; UNITED STATES;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HARM REDUCTION; HUMANS; MODELS, STATISTICAL; RISK; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85032809943     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntx070     Document Type: Article

References (31)

1. US Department of Health and Human Services (US DHHS). The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. www.surgeongeneral.gov/library/reports/50-years-of-progress/index. html#fullreport, www.surgeongeneral.gov/library/reports/50-years-of-progress/ sgr50-chap-15-appendix.pdf. Accessed March 30, 2017.
2. Vugrin ED, Rostron BL, Verzi SJ, et al. Modeling the potential effects of new tobacco products and policies: a dynamic population model for multiple product use and harm. PLOS ONE. 2015;10(3):e0121008. doi:10.1371/journal.pone.0121008.
3. Cobb CO, Villanti AC, Graham AL, et al. Markov modeling to estimate the population impact of emerging tobacco products: a proof-of-concept study. Tob Reg Sci. 2015;1(2):129-141. doi:10.18001/TRS.1.2.3.
4. Weitkunat R, Lee PN, Baker G, Sponsiello-Wang Z, González-Zuloeta Ladd AM, Lüdicke F. A novel approach to assess the population health impact of introducing a modified risk tobacco product. Regul Toxicol Pharmacol. 2015;72(1):87-93. doi:10.1016/j.yrtph.2015.03.011.
5. Bachand AM, Sulsky SI. A dynamic population model for estimating allcause mortality due to lifetime exposure history. Regul Toxicol Pharmacol. 2013;67(2):246-251. doi:10.1016/j.yrtph.2013.08.003.
6. Levy DT, Borland R, Villanti AC, et al. The application of a decisiontheoretic model to estimate the public health impact of vaporized nicotine product initiation in the United States. Nicotine Tob Res. 2017;19(2):149-159. doi:10.1093/ntr/ntw158.
7. US Food and Drug Administration (US FDA). Modified Risk Tobacco Product Applications, Draft Guidance. 2012. www.fda.gov/downloads/ TobaccoProducts/GuidanceComplianceRegulatoryInformation/ UCM297751.pdf. Accessed March 30, 2017.
8. Farsalinos KE, Romagna G, Voudris V. Factors associated with dual use of tobacco and electronic cigarettes: a case control study. Int J Drug Policy. 2015;26(6):595-600. doi:10.1016/j.drugpo.2015.01.006.
9. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smokingrelated mortality in the United States. N Engl J Med. 2013;368(4):351-64. doi:10.1056/NEJMsa1211127.
10. Thun MJ, Myers DG, Day-Lally C, et al. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. Chapter 5 In: Burns DM, Garfinkel L, Samet JM, eds., Smoking and Tobacco Control Monograph No. 8: Changes in Cigaretterelated Disease Risks and Their Implications for Prevention and Control. Bethesda, MD: National Cancer Institute, U.S. National Institutes of Health; 1997: 383-475. NIH Publication No. 97-4213. http://cancercontrol. cancer.gov/brp/tcrb/monographs/8/. Accessed March 30, 2017.
11. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14(5):315-320.
12. Jacobs DR Jr, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med. 1999;159(7):733-740.
13. Friedman GD, Tekawa I, Sadler M, Sidney S. Smoking and mortality: The Kaiser Permanente experience. Chapter 6 In: Burns DM, Garfinkel L, Samet JM, eds., Smoking and Tobacco Control Monograph No. 8: Changes in Cigarette-related Disease Risks and Their Implications for Prevention and Control. Bethesda, MD: National Cancer Institute, U.S. National Institutes of Health; 1997: 477-500. NIH Publication No. 97-4213. http://cancercontrol. cancer.gov/brp/tcrb/monographs/8/. Accessed March 30, 2017.
14. Schane RE, Ling PM, Glantz SA. Health effects of light and intermittent smoking: a review. Circulation. 2010;121(13):1518-1522. doi:10.1161/ CIRCULATIONAHA.109.904235.
15. Mendez D, Warner KE. The relative risk of death for former smokers: the influence of age and years-quit. Unpublished research monograph. 2001. www.umich.edu/~dmendez/tobacco/RRiskmonograph.doc. Accessed March 30, 2017.
16. Begh R, Lindson-Hawley N, Aveyard P. Does reduced smoking if you can't stop make any difference? BMC Med. 2015;13:257. doi:10.1186/ s12916-015-0505-2.
17. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control. 2006;15(6):472-480.
18. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007;9(6):631-646.
19. Hart C, Gruer L, Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. Am J Epidemiol. 2013;178(5):770-779. doi:10.1093/ aje/kwt038.
20. Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol. 2012;175(10):1006-1012. doi:10.1093/aje/kwr466.
21. Lee PN. The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)-a review. Regul Toxicol Pharmacol. 2013;67(3):372-381. doi:10.1016/j. yrtph.2013.08.016.
22. Lee PN. Health risks related to dual use of cigarettes and snus - a systematic review. Regul Toxicol Pharmacol. 2014;69(1):125-134. doi:10.1016/j. yrtph.2013.10.007.
23. Miller LS, Max W, Sung HY, Rice D, Zaretsky M. Evaluation of the economic impact of California's Tobacco Control Program: a dynamic model approach. Tob Control. 2010;19(suppl 1):i68-i76. doi:10.1136/ tc.2008.029421.
24. Holford TR, Clark L. Development of the counterfactual smoking histories used to assess the effects of tobacco control. Risk Anal. 2012;32(suppl 1):S39-S50. doi:10.1111/j.1539-6924.2011.01759.x.
25. McMahon PM, Hazelton WD, Kimmel M, Clarke LD. CISNET lung models: comparison of model assumptions and model structures. Risk Anal. 2012;32(suppl 1):S166-S178. doi:10.1111/j.1539-6924.2011.01714.x.
26. Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Anal. 2012;32(suppl 1):S51-S68. doi:10.1111/j. 1539-6924.2011.01775.x.
27. Hazelton WD, Jeon J, Meza R, Moolgavkar SH. The FHCRC lung cancer model. Risk Anal. 2012;32(suppl 1):S99-S116. doi:10.1111/j.1539-6924. 2011.01681.x.
28. Lee PN, Hamling J, Fry J, Forey B. Using the negative exponential model to describe changes in risk of smoking-related diseases following changes in exposure to tobacco. Advances in Epidemiology. 2015;13:Article ID. 487876. doi:10.1155/2015/487876.
29. Lee PN, Fry JS, Hamling JS. Using the negative exponential distribution to quantitatively review the evidence on how rapidly the excess risk of ischaemic heart disease declines following quitting smoking. Regul Toxicol Pharmacol. 2012;64(1):51-67. doi:10.1016/j.yrtph.2012.06.009.
30. Bonnie RJ, Stratton K, Wallace RB, eds. Ending the Tobacco Problem: A Blueprint for the Nation. Washington, DC: The National Academies Press; 2007. Levy DT, Appendix J:578-598. www.nap.edu/catalog/11795/ ending-the-tobacco-problem-a-blueprint-for-the-nation. Accessed March 30, 2017.
31. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi:10.1371/annotation/e12c22d3-a42b-455d-9100-6c7ee45d58d0.